Insurance Trends in Patients Diagnosed with Melanoma Before and After the Affordable Care Act: A National Database Study
Authors:
Open Access
- 30 April 2023
- journal article
- research article
- Published by Athenaeum Scientific Publishers in Journal of Dermatology Research
Abstract
Background: The Affordable Care Act (ACA) was intended, in part, to reduce the uninsured population. It underwent full implementation in 2014 with optional state Medicaid expansion and health insurance marketplaces. Prior to the ACA, studies show that insurance status affects cancer care, including prevention, diagnosis, stage at diagnosis, and management. ACA impact on malignant melanoma is unknown. In this study, the primary objective is to examine the impact of the ACA on insurance rates among patients diagnosed with malignant melanoma. Survival by insurance type was also assessed. Methods: A retrospective analysis of the Surveillance, Epidemiology and End Results (SEER) cancer registry was performed for malignant melanoma between 2007 (first year of insurance da-ta in SEER) and 2015. Standardized mean differences were used for 2007-2013 and 2014-2015 (after full ACA implementation) for the primary objective. Sub-analysis was performed for Med-icaid expansion and non-expansion states. The impact of insurance type (uninsured, Medicaid, non-Medicaid) on all-cause and cause-specific mortality was assessed via adjusted cox regression models. Results: Nationally, the ACA decreased percentage of uninsured patients (-1.12% to -2.26%, P<0.05) and increased percentage of Medicaid enrollees (+1.53% to +4.02%, P<.005) diagnosed with malignant melanoma. Expansion states showed decreased percentage of uninsured patients (-1.43% to -2.24%, P<0.05) and increased percentage of Medicaid enrollees (+1.66% to +4.84%, P<0.05). Non-expansion states showed no change in percentages of uninsured patients and Medicaid enrollees. All-cause and cause-specific mortality were decreased in uninsured and Medicaid patients diagnosed with malignant melanoma compared to non-Medicaid insured patients (reference group). Discussion: The ACA decreased the rate of patients diagnosed with malignant melanoma with uninsured status, but this was only significant in Medicaid expansion states. Although diagnosis of melanoma is associated with High Socioeconomic Status (SES), Medicaid expansion seems to have increased access to dermatologic care. Increasing the number of states expanding Medicaid may be beneficial. However, Medicaid patient have worse all-cause and cause-specific mortality compared to non-Medicaid insured patients. Addressing these disparities through policy is important to ensure insurance coverage translates to better outcomes.Keywords
This publication has 30 references indexed in Scilit:
- Association of the Patient Protection and Affordable Care Act With Insurance Coverage for Head and Neck Cancer in the SEER DatabaseJAMA Otolaryngology–Head & Neck Surgery, 2018
- Factors associated with advanced-stage Merkel cell carcinoma at initial diagnosis and the use of radiation therapy: Results from the National Cancer DatabaseJournal of the American Academy of Dermatology, 2018
- United States Health Care ReformJAMA, 2016
- Screening for Skin Cancer in AdultsJAMA, 2016
- Associations among socioeconomic status, patterns of care, and outcomes in breast cancer patients in a universal health care system: Ontario's experienceCancer, 2015
- Medicaid expansion and access to care among cancer survivors: a baseline overviewJournal of Cancer Survivorship, 2015
- An Analysis of Dermatologist Migration Patterns After Residency TrainingArchives of Dermatology, 2011
- The impact of health insurance status on the survival of patients with head and neck cancerCancer, 2009
- California Medicaid Enrollment and Melanoma Stage at DiagnosisAmerican Journal of Preventive Medicine, 2008
- The impact of health insurance status on stage at diagnosis of oropharyngeal cancerCancer, 2007